InterCure to Participate in Cowen 5th Annual Cannabis Conference

Rhea-AI Summary

InterCure Ltd (NASDAQ: INCR) announced CEO Alexander Rabinovitch will participate in the Cowen 5th Annual Cannabis Conference on December 8, 2022. He will join an industry leaders panel at 9:30 AM EST and conduct one-on-one sessions by appointment. InterCure, operating as Canndoc, stands as Israel's largest licensed cannabis producer, leading the cannabis market outside North America with a high-margin 'seed-to-sale' model.

For more information, visit InterCure's website.

News Market Reaction – INCR

-0.85%

-0.85% Session move

In the trading session that priced this news, INCR declined 0.85%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Mr. Rabinovitch is one of the global cannabis senior executives to participate

NEW YORK and TORONTO and HERZLIYA, Israel, Dec. 08, 2022 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure" or the “Company”) today announced that Alexander Rabinovitch, CEO of InterCure, will participate in Cowen 5^th Annual Cannabis Conference, taking place December 8^th, 2022.

Mr. Rabinovitch will take part in the industry leaders panel on Thursday, December 8^th, 2022 at 9:30 AM EST, and will be available for 1 on 1 sessions by appointment only.

About InterCure (dba Canndoc)

InterCure (dba Canndoc) (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) is the leading, profitable, and fastest growing cannabis company outside of North America. Canndoc, a wholly owned subsidiary of InterCure, is Israel’s largest licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products. InterCure leverages its market leading distribution network, best in class international partnerships and a high-margin vertically integrated "seed-to-sale" model to lead the fastest growing cannabis global market outside of North America.

For more information, visit: http://www.intercure.co.

Contact:

InterCure Ltd.
Amos Cohen, Chief Financial Officer
amos@intercure.co 

FAQ

What event is InterCure's CEO participating in?

InterCure's CEO, Alexander Rabinovitch, will participate in the Cowen 5th Annual Cannabis Conference on December 8, 2022.

When is Alexander Rabinovitch speaking at the conference?

He will speak at the conference on December 8, 2022, at 9:30 AM EST.

What company does Alexander Rabinovitch lead?

He leads InterCure Ltd, which operates as Canndoc.

What is InterCure known for?

InterCure is known as Israel's largest licensed cannabis producer and a leading company in the cannabis market outside of North America.

What is InterCure's business model?

InterCure utilizes a high-margin 'seed-to-sale' vertically integrated model in the cannabis industry.